The astrocytes of individuals with AD demonstrate augmented compensatory expression of the receptors for SPM resolvin E1, specifically the leukotriene B4 receptor (BLT1) and chemoattractant receptor 23 (ChemR23), along with heightened levels of the inflammatory marker YKL-40. Here, LTB4R is linked to Alzheimer disease.